Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Evolus Analyst Ratings and Price Targets | NASDAQ:EOLS | Benzinga
Evolus Inc has a consensus price target of $22.63 based on the ratings of 9 analysts. The high is $27 issued by HC Wainwright & Co. on April 10, 2025. The low is $18 issued by Truist Securities on May 26, 2023. The 3 most-recent analyst ratings were released by Needham, BTIG, and HC Wainwright & Co. on May 8, 2025, April 17, 2025, and April 10, 2025, respectively. With an average price target of $23.33 between Needham, BTIG, and HC Wainwright & Co., there's an implied 147.83% upside for Evolus Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Needham
BTIG
HC Wainwright & Co.
Barclays
Stifel
1calculated from analyst ratings
Analyst Ratings for Evolus
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
05/08/2025 | 133.67% | Needham | $22 → $22 | Reiterates | Buy → Buy | |||
04/17/2025 | 123.05% | BTIG | → $21 | Initiates | → Buy | |||
04/10/2025 | 186.78% | HC Wainwright & Co. | $27 → $27 | Reiterates | Buy → Buy | |||
04/09/2025 | 133.67% | Needham | $22 → $22 | Reiterates | Buy → Buy | |||
03/05/2025 | 165.53% | Barclays | $22 → $25 | Maintains | Overweight | |||
03/05/2025 | 186.78% | HC Wainwright & Co. | $27 → $27 | Reiterates | Buy → Buy | |||
03/05/2025 | 133.67% | Needham | $22 → $22 | Reiterates | Buy → Buy | |||
02/14/2025 | 186.78% | HC Wainwright & Co. | $27 → $27 | Reiterates | Buy → Buy | |||
01/27/2025 | 133.67% | Barclays | $20 → $22 | Maintains | Overweight | |||
01/22/2025 | 186.78% | HC Wainwright & Co. | $27 → $27 | Reiterates | Buy → Buy | |||
01/21/2025 | 133.67% | Needham | $22 → $22 | Reiterates | Buy → Buy | |||
11/07/2024 | 186.78% | HC Wainwright & Co. | $27 → $27 | Reiterates | Buy → Buy | |||
11/01/2024 | 186.78% | HC Wainwright & Co. | $27 → $27 | Reiterates | Buy → Buy | |||
10/03/2024 | 186.78% | HC Wainwright & Co. | $27 → $27 | Reiterates | Buy → Buy | |||
09/16/2024 | — | Cantor Fitzgerald | — | Reiterates | → Overweight | |||
09/13/2024 | 112.43% | Barclays | $16 → $20 | Maintains | Overweight | |||
09/13/2024 | 133.67% | Needham | $22 → $22 | Reiterates | Buy → Buy | |||
09/09/2024 | — | Cantor Fitzgerald | — | Reiterates | → Overweight | |||
08/01/2024 | 186.78% | HC Wainwright & Co. | $27 → $27 | Reiterates | Buy → Buy | |||
08/01/2024 | 133.67% | Needham | $22 → $22 | Reiterates | Buy → Buy | |||
06/20/2024 | — | Cantor Fitzgerald | — | Reiterates | → Overweight | |||
05/21/2024 | 186.78% | HC Wainwright & Co. | $27 → $27 | Reiterates | Buy → Buy | |||
05/08/2024 | 133.67% | Needham | $22 → $22 | Reiterates | Buy → Buy | |||
05/08/2024 | 186.78% | HC Wainwright & Co. | $27 → $27 | Reiterates | Buy → Buy | |||
04/10/2024 | 133.67% | Needham | $22 → $22 | Reiterates | Buy → Buy | |||
03/08/2024 | 133.67% | Needham | $22 → $22 | Reiterates | Buy → Buy | |||
03/08/2024 | 186.78% | HC Wainwright & Co. | $27 → $27 | Reiterates | Buy → Buy | |||
03/08/2024 | 165.53% | Stifel | $23 → $25 | Reiterates | Buy → Buy | |||
03/08/2024 | 144.29% | Mizuho | $20 → $23 | Maintains | Buy | |||
03/01/2024 | 186.78% | HC Wainwright & Co. | $27 → $27 | Reiterates | Buy → Buy | |||
01/29/2024 | 69.94% | Barclays | $10 → $16 | Upgrade | Equal-Weight → Overweight | |||
01/17/2024 | 186.78% | HC Wainwright & Co. | $27 → $27 | Reiterates | Buy → Buy | |||
12/20/2023 | 133.67% | Needham | $22 → $22 | Reiterates | Buy → Buy | |||
08/03/2023 | 186.78% | HC Wainwright & Co. | $16 → $27 | Maintains | Buy | |||
08/03/2023 | 133.67% | Needham | → $22 | Reiterates | Buy → Buy | |||
07/28/2023 | 69.94% | HC Wainwright & Co. | → $16 | Reiterates | Buy → Buy | |||
06/07/2023 | 112.43% | Mizuho | $17 → $20 | Maintains | Buy | |||
05/26/2023 | 91.18% | Truist Securities | $14 → $18 | Maintains | Buy | |||
05/10/2023 | 133.67% | Needham | $18 → $22 | Maintains | Buy | |||
05/10/2023 | 69.94% | HC Wainwright & Co. | $15 → $16 | Maintains | Buy | |||
03/09/2023 | 91.18% | Needham | → $18 | Reiterates | → Buy | |||
03/09/2023 | 59.32% | HC Wainwright & Co. | → $15 | Reiterates | → Buy | |||
02/13/2023 | 91.18% | Needham | → $18 | Reiterates | → Buy | |||
01/19/2023 | 80.56% | Mizuho | $15 → $17 | Maintains | Buy | |||
01/19/2023 | 112.43% | SVB Leerink | $18 → $20 | Maintains | Outperform |
FAQ
What is the target price for Evolus (EOLS) stock?
The latest price target for Evolus (NASDAQ:EOLS) was reported by Needham on May 8, 2025. The analyst firm set a price target for $22.00 expecting EOLS to rise to within 12 months (a possible 133.67% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Evolus (EOLS)?
The latest analyst rating for Evolus (NASDAQ:EOLS) was provided by Needham, and Evolus reiterated their buy rating.
When was the last upgrade for Evolus (EOLS)?
The last upgrade for Evolus Inc happened on January 29, 2024 when Barclays raised their price target to $16. Barclays previously had an equal-weight for Evolus Inc.
When was the last downgrade for Evolus (EOLS)?
There is no last downgrade for Evolus.
When is the next analyst rating going to be posted or updated for Evolus (EOLS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evolus, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evolus was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.
Is the Analyst Rating Evolus (EOLS) correct?
While ratings are subjective and will change, the latest Evolus (EOLS) rating was a reiterated with a price target of $22.00 to $22.00. The current price Evolus (EOLS) is trading at is $9.41, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
